Zenith Drugs
Zenith Drugs Share Price Chart
Zenith Drugs last traded at ₹41.00 (2026-10-13). Over the past month the stock moved -11.5%, three months the stock moved -11.7%, year the stock moved -39.8%. Its closing range over 52 weeks is ₹38.10 – ₹65.15, with the latest close 37.1% below the high.
Closing prices up to 2026-10-13.
About Zenith Drugs
Incorporated in 2000, Zenith Drugs Ltd is in the business of manufacturing and trading of medicines[1]
Business Overview:[1][2] ZDL is a manufacturer of a range of healthcare drugs and allied products which includes pharmaceutical formulations. It also caters to a diverse range of customers and generates revenue through various avenues, such as marketing of branded generic drugs, third-party job work manufacturing, government and institutional business, and exports through merchant dealers.
Fundamentals
Quarterly Results
In the latest quarter (Mar 2026), Zenith Drugs reported sales of ₹93.00 crore (+50.0%) and net profit of ₹2.00 crore (-50.0%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 93.00 | 6.00 | 6.00 | 2.00 | 0.94 |
| Sep 2025 | 78.00 | 6.00 | 8.00 | 2.00 | 1.36 |
| Mar 2025 | 66.00 | 7.00 | 10.00 | 1.00 | 0.84 |
| Sep 2024 | 68.00 | 7.00 | 10.00 | 6.00 | 3.34 |
| Mar 2024 | 62.00 | 6.00 | 9.00 | 4.00 | 2.24 |
| Sep 2023 | 69.00 | 11.00 | 16.00 | 6.00 | 4.75 |
| Sep 2025 | Mar 2026 | |
|---|---|---|
| Sales growth | +13.0% | +50.0% |
| Operating profit growth | -45.5% | +0.0% |
| Net profit growth | -66.7% | -50.0% |
| EPS growth | -71.4% | -58.0% |
| OPM % | 8.0% | 6.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Zenith Drugs reported sales of ₹171.00 crore (+28.6%) and net profit of ₹4.00 crore (-42.9%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 171.00 | 12.00 | 7.00 | 4.00 | 2.30 |
| Mar 2025 | 133.00 | 14.00 | 10.00 | 7.00 | 4.18 |
| Mar 2024 | 132.00 | 17.00 | 13.00 | 10.00 | 5.56 |
| Mar 2023 | 115.00 | 9.00 | 8.00 | 5.00 | – |
| Mar 2022 | 92.00 | 7.00 | 8.00 | 3.00 | – |
| Mar 2021 | 72.00 | 7.00 | 10.00 | 3.00 | – |
| Mar 2020 | 78.00 | 7.00 | 9.00 | 3.00 | – |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Sales growth | -7.7% | +27.8% | +25.0% | +14.8% | +0.8% | +28.6% |
| Operating profit growth | +0.0% | +0.0% | +28.6% | +88.9% | -17.6% | -14.3% |
| Net profit growth | +0.0% | +0.0% | +66.7% | +100.0% | -30.0% | -42.9% |
| EPS growth | – | – | – | – | -24.8% | -45.0% |
| OPM % | 10.0% | 8.0% | 8.0% | 13.0% | 10.0% | 7.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Zenith Drugs.
Get Free AI Stock Analysis FREE →Latest News
-
Zenith Drugs shareholders approve 16.9 lakh FCW issuance to promoters - scanx.trade
Frequently Asked Questions
What is Zenith Drugs's current stock price?
Zenith Drugs shares were last quoted at ₹41.00 (+1.0% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Zenith Drugs?
Zenith Drugs has a price-to-earnings (P/E) ratio of 7.60 and a price-to-book (P/B) ratio of 1.18. The industry P/E is 53.33.
What is the 52-week high and low of Zenith Drugs?
The 52-week high of Zenith Drugs is ₹73.45 and the 52-week low is ₹33.30.
What is the market cap of Zenith Drugs?
The market capitalisation of Zenith Drugs is about ₹73.40 crore.
How did Zenith Drugs perform in its latest quarterly results?
In the latest quarter (Mar 2026), Zenith Drugs reported sales of ₹93.00 crore (+50.0%) and net profit of ₹2.00 crore (-50.0%), compared with the same quarter last year.
Is Zenith Drugs a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Zenith Drugs has a 3-year ROE of 12.00%, 3-year profit growth of -5.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Zenith Drugs?
Promoters hold about 69.98% of Zenith Drugs.
Which sector does Zenith Drugs belong to?
Zenith Drugs belongs to the Pharmaceuticals & Drugs sector.